NeuroSpeechAI revolutionizes therapy for brain injury, stroke, and dementia patients through a suite of seven innovative apps. Incorporated in April 2023 as a UCL spinout by Professors Alex Leff, Jenny Crinion, and William Latham, we merge advanced mobile game development with a groundbreaking, tailored speech recognition system.
Our apps are designed to understand and support distorted speech, enabling patients to use them independently for home-based therapy, while providing immediate, robust feedback on their progress.
Our technology not only offers personalized therapeutic exercises but also employs algorithmic AI to continuously enhance the platform based on user performance data. This approach ensures that each patient's experience is engaging, effective, and directly contributes to the improvement of their recovery.
Available for both mobile and desktop, NeuroSpeechAI's mission is to make quality therapy accessible to everyone affected by acquired cognitive, visual, and language disorders. By offering our apps on a global scale, we aim to speed up recovery and significantly improve the quality of life for our users, all from the comfort of their home.
Dedicated to breaking down barriers in therapy access, NeuroSpeechAI is a testament to the power of combining medical research with digital innovation to create real-world solutions for those in need.
Company Details
- Founded
- -
- Address
- London, Gb
- Industry
- Mobile Gaming Apps
- Website
- https://neurospeechai.com
- Keywords
- Ethera Health.
- HQ
- london
Neurospeechai Questions
Neurospeechai's website is https://neurospeechai.com
Neurospeechai's LinkedIn profile is https://uk.linkedin.com/company/neurospeechai
Neurospeechai's industry is
Mobile Gaming Apps
Neurospeechai's top competitors are
Phenopolis,
Shiftpartner Limited,
Ethera Health,
Affiniti Ai,
Cleo Systems,
Abycloud Ltd,
Storegene,
Eye2gene.
Neurospeechai's categories are Mobile Gaming Apps
Neurospeechai's founding year is 2023
